Patents-Review.com
🔗 Permalink
Assignee profile:

ATHERSYS, INC.

City:

Cleveland, Ohio

Country:

United States

Published Applications:

29

Last publication date:

2018-11-08

Patent Grants:

27

Last grant date:

2021-05-11

Top Inventors for applications by ATHERSYS, INC.

These are the the leading inventors for applications assigned to ATHERSYS, INC.:

Recent patent applications by ATHERSYS, INC.

ATHERSYS, INC. based in Cleveland, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2018-11-08 ✅ Patent 11,000,546 granted on 2021-05-11
US20180318346A1
Human necessities

Immunomodulatory properties of MAPCs and uses thereof

 #2 | 2018-05-03 ✅ Patent 10,117,900 granted on 2018-11-06
US20180117093A9
Human necessities

MAPC treatment of brain injuries and diseases

 #3 | 2018-03-01 ✅ Patent 11,197,889 granted on 2021-12-14
US20180055881A1
Human necessities

Immunomodulatory properties of multipotent adult progenitor cells and uses thereof

 #4 | 2012-10-04 ✅ Patent 8,716,324 granted on 2014-05-06
US20120252859A1
Chemistry; metallurgy

Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators

 #5 | 2012-05-31 ✅ Patent 9,808,485 granted on 2017-11-07
US20120135043A1
Human necessities

Immunomodulatory properties of multipotent adult progenitor cells and uses thereof

 #6 | 2011-07-14 ✅ Patent 8,232,311 granted on 2012-07-31
US20110172283A1
Chemistry; metallurgy

Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators

 #7 | 2011-05-12 ✅ Patent 7,981,896 granted on 2011-07-19
US20110112088A1
Chemistry; metallurgy

Pyrazoles for the treatment of obesity and other CNS disorders

 #8 | 2011-05-12 ✅ Patent 8,716,276 granted on 2014-05-06
US20110112072A1
Chemistry; metallurgy

Thiophenyl and pyrrolyl azepines as serotonin 5-HTreceptor ligands and uses thereof

 #9 | 2011-03-10 ✅ Patent 8,129,424 granted on 2012-03-06
US20110059966A1
Chemistry; metallurgy

Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders

 #10 | 2010-12-09
US20100310570A1
Human necessities

MAPC TREATMENT OF BRAIN INJURIES AND DISEASES

 #11 | 2010-01-14 ✅ Patent 11,992,507 granted on 2024-05-28
US20100008890A1
Human necessities

MAPC therapeutics without adjunctive immunosuppressive treatment

 #12 | 2009-09-24 ✅ Patent 7,935,830 granted on 2011-05-03
US20090239925A1
Chemistry; metallurgy

Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators

 #13 | 2009-04-23 ✅ Patent 9,962,407 granted on 2018-05-08
US20090104163A1
Human necessities

Immunomodulatory properties of multipotent adult progenitor cells and uses thereof

 #14 | 2009-03-12 ✅ Patent 7,981,919 granted on 2011-07-19
US20090069365A1
Chemistry; metallurgy

Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators

 #15 | 2009-02-05 ✅ Patent 7,855,224 granted on 2010-12-21
US20090036446A1
Chemistry; metallurgy

Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders

 #16 | 2008-11-20 ✅ Patent 7,947,691 granted on 2011-05-24
US20080287465A1
Chemistry; metallurgy

Cyclic n-hydroxy imides as inhibitors of flap endonuclease and uses thereof

 #17 | 2008-01-08 ✅ Patent 7,316,923 granted on 2008-01-08
US9484895
-

Compositions and methods for non-targeted activation of endogenous genes

 #18 | 2007-08-23 ✅ Patent 7,897,634 granted on 2011-03-01
US20070197526A1
Chemistry; metallurgy

Pyrazoles for the treatment of obesity and other CNS disorders

 #19 | 2007-08-16 ✅ Patent 7,893,051 granted on 2011-02-22
US20070191342A1
Chemistry; metallurgy

Thiophenyl and pyrrolyl azepines as serotonin 5-HTreceptor ligands and uses thereof

 #20 | 2007-08-02 ✅ Patent 7,569,220 granted on 2009-08-04
US20070178585A1
Chemistry; metallurgy

Compositions and methods for non-targeted activation of endogenous genes

 #21 | 2007-07-12 ✅ Patent 7,528,262 granted on 2009-05-05
US20070161676A1
Chemistry; metallurgy

Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders

 #22 | 2007-05-31
US20070122391A1
Chemistry; metallurgy

Compositions and methods for non-targeted activation of endogenous genes

 #23 | 2006-11-23 ✅ Patent 8,147,824 granted on 2012-04-03
US20060263337A1
Human necessities

Immunomodulatory properties of multipotent adult progenitor cells and uses thereof

 #24 | 2006-04-25 ✅ Patent 7,033,782 granted on 2006-04-25
US9760897
-

Compositions and methods for non-targeted activation of endogenous genes

 #25 | 2006-04-13 ✅ Patent 7,423,056 granted on 2008-09-09
US20060079567A1
Chemistry; metallurgy

Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators

 #26 | 2006-01-12 ✅ Patent 7,319,103 granted on 2008-01-15
US20060009451A1
Chemistry; metallurgy

Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders

 #27 | 2006-01-05 ✅ Patent 7,718,647 granted on 2010-05-18
US20060003990A1
Chemistry; metallurgy

Substituted azepine derivatives as serotonin receptor modulators

 #28 | 2005-08-18 ✅ Patent 10,226,485 granted on 2019-03-12
US20050181502A1
Human necessities

Multipotent adult stem cells and methods for isolation

 #29 | 2005-05-24 ✅ Patent 6,897,066 granted on 2005-05-24
US9276820
-

Compositions and methods for non-targeted activation of endogenous genes

Also check out ATHERSYS, INC.'s (Cleveland, United States) applicant profile with 2 patent applications submitted.

AssigneeID:

132598 ⎘